Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2006 | A membrane antibody receptor for noninvasive imaging of gene expression | Roffler, S. R.; Wang, H. E.; Yu, H. M.; Chang, W. D.; Cheng, C. M.; Lu, Y. L.; Chen, B. M.; Cheng, T. L. | Gene Ther 13, 412-420 | | | |
1999 | Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM | Cheng, T. L.; Wu, P. Y.; Wu, M. F.; Chern, J. W.; Roffler, S. R. | Bioconjugate Chemistry 10, 520-528 | | | |
2003 | Anti-4-1BB-based immunotherapy for autoimmune diabetes: lessons from a transgenic non-obese diabetic (NOD) model | Sytwu, H. K.; Lin, W. D.; Roffler, S. R.; Hung, J. T.; Sung, H. S.; Wang, C. H.; Cheng, T. L.; Tsou, S. C.; Hsi, S. C.; Shen, K. L. | J Autoimmun 21, 247-254 | | | |
1999 | Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug | Cheng, T. L.; Wei, S. L.; Chen, B. M.; Chern, J. W.; Wu, M. F.; Liu, P. W.; Roffler, S. R. | British Journal of Cancer 79, 1378-1385 | | | |
2000 | Characterization of a tumor-specific antigen expressing on Chang hepatoma ascites cells | Lin, S. C.; Roffler, S. R.; Cheng, T. L.; Chang, K. T.; Chang, J. P.; Wang, J. J. | Acta Histochemica et Cytochemica 33, 367-375 | | | |
1999 | Characterization of an antineoplastic glucuronide prodrug | Cheng, T. L.; Chou, W. C.; Chen, B. M.; Chern, J. W.; Roffler, S. R. | Biochem Pharmacol 58, 325-328 | | | |
2006 | Combination cancer therapy by hapten-targeted prodrug-activating enzymes and cytokines | Chuang, K. H.; Cheng, C. M.; Roffler, S. R.; Lu, Y. L.; Lin, S. R.; Wang, J. J.; Tzou, W. S.; Su, Y. C.; Chen, B. M.; Cheng, T. L. | Bioconjugate Chem 17, 707-714 | | | |
2007 | Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor destructive immune responses | Tuve, S.; Chen, B. M.; Liu, Y.; Cheng, T. L.; Toure, P.; Sow, P. S.; Feng, Q.; Kiviat, N.; Strauss, R.; Ni, S.; Li, Z. Y.; Roffler, S. R.; Lieber, A. | Cancer Research 67(12), 5929-5939 | | | |
2003 | Directional shape complementarity at the protein-DNA interface | Yeh, C. S.; Chen, F. M.; Wang, J. Y.; Cheng, T. L.; Hwang, M. J. ; Tzou, W. S. | J Mol Recognit 16, 213-222 | | | |
2000 | Efficient clearance of poly(ethylene glycol)-modified immunoenzyme with anti-PEG monoclonal antibody for prodrug cancer therapy | Cheng, T. L.; Chen, B. M.; Chern, J. W.; Wu, M. F.; Roffler, S. R. | Bioconjugate Chemistry 11, 258-266 | | | |
2007 | Gene expression imaging by enzymatic catalysis of a fluorescent probe via membrane-anchored beta-glucuronidase | Su, Y. C.; Chuang, K. H.; Wang, Y. M.; Cheng, C. M.; Lin, S. R.; Wang, J. Y.; Hwang, J. J.; Chen, B. M.; Chen, K. C.; Roffler, S. R.; Cheng, T. L. | Gene Ther 14(7), 565-574 | | | |
2004 | Hapten-directed targeting to single-chain antibody receptors | Cheng, T. L.; Liao, K. W.; Tzou, S. C.; Cheng, C. M.; Chen, B. M.; Roffler, S. R. | Cancer Gene Ther 11, 380-388 | | | |
2007 | Membrane-localized activation of glucuronide prodrugs by beta-glucuronidase enzymes | Chen, K. C.; Cheng, T. L.; Leu, Y. L.; Prijovich, Z. M.; Chuang, C. H.; Chen, B. M.; Roffler, S. R. | Cancer Gene Ther 14(2), 187-200 | | | |
2008 | Membrane-tethered proteins for basic research, imaging and therapy | Cheng, T. L.; Roffler, S. R. | Medicinal Research Reviews 28, 885-928 | | | |
2003 | Monoclonal antibody for analysis and clearance of polyethylene glycol and polyethylene glycol- modified molecules | Roffler, S. R.; Cheng, T. L.; Wu, P. Y. | US Patent 6,596,849 | | | |
1997 | Poly(ethylene glycol) modification of beta-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs | Cheng, T. L.; Chen, B. M.; Chan, L. Y.; Wu, P. Y.; Chern, J. W.; Roffler, S. R. | Cancer Immunol Immunother 44, 305-315 | | | |
2001 | Potentiation of antitumor immunity by antibody-directed enzyme prodrug therapy | Chen, B. M.; Cheng, T. L.; Tzou, S. C.; Roffler, S. R. | Int J Cancer 94, 850-858 | | | |
2001 | Sensitive measurement of polyethylene glycol-modified proteins | Tsai, N. M.; Cheng, T. L.; Roffler, S. R. | Biotechniques 30, 396-402 | | | |